Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/06/1997WO1997041233A1 Antiviral ricin-like proteins
11/06/1997WO1997041232A1 Antagonists of interleukin-15
11/06/1997WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997WO1997041230A2 Cc-type chemokines
11/06/1997WO1997041229A1 Antibodies against interferon alpha/beta receptor
11/06/1997WO1997041226A2 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor
11/06/1997WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997WO1997041223A1 Molecular clone of cgrp receptor component protein and uses thereof
11/06/1997WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
11/06/1997WO1997041221A1 Metastasis-associated antigen and antibodies thereto
11/06/1997WO1997041220A1 Von willebrand factor peptide derivatives and use therof as coagulant
11/06/1997WO1997041206A2 Von willebrand factor multimerase
11/06/1997WO1997041156A1 Novel compounds
11/06/1997WO1997041155A2 Compositions and methods for isolating lung surfactant hydrophobic proteins sp-b and sp-c
11/06/1997WO1997041154A1 Eosinophil eotaxin receptor
11/06/1997WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997WO1997041150A2 Gene therapy for mitochondrial dna deffects using peptide nucleic acids
11/06/1997WO1997041149A1 Peptide compositions which induce immune tolerance and methods of use
11/06/1997WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
11/06/1997WO1997041147A1 Novel compounds
11/06/1997WO1997041146A1 Novel compounds
11/06/1997WO1997041143A1 Novel synaptogyrin homolog
11/06/1997WO1997041141A1 Methods and compounds for curing diseases caused by mutations
11/06/1997WO1997041136A1 Suppressor mutations for common p53 cancer mutations
11/06/1997WO1997041135A1 Novel compounds
11/06/1997WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
11/06/1997WO1997040864A1 Method for making autologous fibrin sealant
11/06/1997WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997WO1997040857A1 Drug delivery using terminal complement components
11/06/1997WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997WO1997040853A1 Pharmacologic, therapeutic and diagnostic regulation of fgf-1 export
11/06/1997WO1997040852A1 Improving binding affinity of antigenic peptides for mhc molecules
11/06/1997WO1997040851A1 Novel compounds
11/06/1997WO1997040850A1 Erythropoietin solution preparation
11/06/1997WO1997040849A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997WO1997040848A1 Use of prolactin as a tgf-beta antagonist
11/06/1997WO1997040847A1 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
11/06/1997WO1997040846A1 COMBINED USE OF GnRH AGONIST AND ANTAGONIST
11/06/1997WO1997040840A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
11/06/1997WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals
11/06/1997WO1997040819A1 Methods of dry powder inhalation
11/06/1997WO1997040811A1 Storage stable dentifrice composition containing casein glycomacropeptide
11/06/1997WO1997040809A2 METHOD OF ENHANCING EFFECT OF NEUROTROPHIN WITH ANALOGUES OF p75NTR367-379
11/06/1997WO1997035969A3 Peptide ligands of the urokinase receptor
11/06/1997WO1997033608A3 Antagonism of endothelin actions
11/06/1997WO1997032598A3 Vaccines
11/06/1997WO1997027284A3 Human rad50 and septin-2 genes and methods of use
11/06/1997DE19617203A1 Recombinant interleukin 16
11/06/1997DE19617202A1 Recombinant interleukin 16
11/06/1997CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997CA2253313A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997CA2253233A1 Process for producing maturation bone morphogenetic protein
11/06/1997CA2252862A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
11/06/1997CA2252850A1 Eosinophil eotaxin receptor
11/06/1997CA2252814A1 Methods of dry powder inhalation
11/06/1997CA2252762A1 Methods and compounds for curing diseases caused by mutations
11/06/1997CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997CA2252557A1 Antagonists of interleukin-15
11/06/1997CA2252469A1 Method of enhancing effect of neurotrophin with analogues of p75ntr367-379
11/06/1997CA2252468A1 Peptide compositions which induce immune tolerance and methods of use
11/06/1997CA2252432A1 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997CA2251813A1 5,6,7,8-tetrahydropyrido¬2,3-d|pyrimidines
11/06/1997CA2232682A1 Use of prolactin as a tgf-beta antagonist
11/06/1997CA2230866A1 Human p2x4 receptor splice-variants
11/05/1997EP0805206A2 Human cartilage glycoprotein
11/05/1997EP0805204A2 Epididymis-specific receptor protein and its use
11/05/1997EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997EP0805162A1 Peptide determinant associated with immunity
11/05/1997EP0805149A1 Novel 2,3-diketopiperazine derivative or salt thereof
11/05/1997EP0804933A2 Storage-stable fibrinogen preparations
11/05/1997EP0804931A2 Peritoneal dialysis solutions and their use to minimize injury to mesothelial cells
11/05/1997EP0804930A1 Novel remedy for respiratory-tract viral disease
11/05/1997EP0804883A2 Animal feed
11/05/1997EP0804728A1 Assay, receptor proteins and ligands
11/05/1997EP0804617A1 Bcl-x/bcl-2 associated cell death regulator
11/05/1997EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997EP0804609A1 NOVEL p53 RESPONSE GENES
11/05/1997EP0804605A2 Liposome-mediated transfection of central nervous system cells
11/05/1997EP0804602A1 Hsv viral vector
11/05/1997EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997EP0804598A1 Recombinant rna viral vector and method of preparing the same
11/05/1997EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
11/05/1997EP0804595A1 Synthetic proteins as implantables
11/05/1997EP0804593A1 Recombinant hk2 polypeptide
11/05/1997EP0804591A1 Serum paraoxonase
11/05/1997EP0804585A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
11/05/1997EP0804584A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
11/05/1997EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/05/1997EP0804580A1 Calcium binding recombinant antibody against protein c
11/05/1997EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor
11/05/1997EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR
11/05/1997EP0804576A1 A novel haemopoietin receptor
11/05/1997EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof
11/05/1997EP0804572A1 Protein tyrosine kinase agonist antibodies
11/05/1997EP0804568A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
11/05/1997EP0804567A1 Method for the ex vivo treatment of tumour cells from patients with cml